# COLLEGIUM PHARMACEUTICAL, INC: Form D filings

COLLEGIUM PHARMACEUTICAL, INC, a pharmaceuticals company in Stoughton, MA, filed 5 Form D notices with the SEC between 2010 and 2018. The latest, on November 13, 2018, reports $20 million sold of a $20 million offering to 1 investor.

Find out what COLLEGIUM PHARMACEUTICAL, INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20COLLEGIUM%20PHARMACEUTICAL%2C%20INC%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=COLLEGIUM%20PHARMACEUTICAL%2C%20INC&page=%2Fdata%2Fform-d%2Fcompany%2Fcollegium-pharmaceutical-inc-1267565)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20COLLEGIUM%20PHARMACEUTICAL%2C%20INC%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=COLLEGIUM%20PHARMACEUTICAL%2C%20INC&page=%2Fdata%2Fform-d%2Fcompany%2Fcollegium-pharmaceutical-inc-1267565)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Massachusetts](https://specstream.ai/data/form-d/state/massachusetts): 1,533 rows, by operating companies, filed since November 1, 2024, $76.65, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/massachusetts
- [Form D filings in Pharmaceuticals](https://specstream.ai/data/form-d/industry/pharmaceuticals): 346 rows, by operating companies, filed since November 1, 2024, $17.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/pharmaceuticals

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 100 TECHNOLOGY CENTER DRIVE, Stoughton, MA, 02072
- Phone: (781) 713-3699
- Industry: Pharmaceuticals
- Entity type: Corporation
- Incorporated in: Virginia
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1267565

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Nov 13, 2018 | New notice | $20,000,006 | $20,000,006 | $0 | 1 | Nov 8, 2018 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1267565/000119248218000472/0001192482-18-000472-index.htm) |
| Mar 13, 2015 | New notice | $50,000,000 | $50,000,000 | $0 | 18 | Mar 6, 2015 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1267565/000119248215000056/0001192482-15-000056-index.htm) |
| Oct 2, 2013 | New notice | $12,000,000 | $4,000,002 | $7,999,998 | 13 | Aug 27, 2013 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1267565/000119248213000180/0001192482-13-000180-index.htm) |
| Feb 24, 2012 | New notice | $22,461,190 | $22,461,190 | $0 | 12 | Feb 10, 2012 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1267565/000119248212000062/0001192482-12-000062-index.htm) |
| Mar 8, 2010 | New notice | $2,500,000 | $1,000,000 | $1,500,000 | 7 | Mar 1, 2010 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1267565/000119248210000031/0001192482-10-000031-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Michael Heffernan | Director |  |
| David Hirsch | Director |  |
| Garen Bohlin | Director |  |
| Shirley B. Kuhlmann | Executive Officer |  |
| Theodore A Schroeder | Director |  |
| John A Fallon | Director |  |
| Alison B. Fleming | Executive Officer |  |
| Gwen A Melincoff | Director |  |
| Gino Santini | Director |  |
| Scott B. Dreyer | Executive Officer |  |
| Joseph Ciaffoni | Executive Officer, Director |  |
| John Freund | Director |  |
| Paul Brannelly | Executive Officer |  |

## Other pharmaceuticals companies in Massachusetts that filed recently

- [BridgeHealth Pharmaceuticals, Inc.](https://specstream.ai/data/form-d/company/bridgehealth-pharmaceuticals-inc-2162724) $3.5 million · Nov 5, 2026
- [Land Therapeutics Inc.](https://specstream.ai/data/form-d/company/land-therapeutics-inc-2051104) $17.5 million · Oct 21, 2026
- [Crosslink Therapeutics Inc.](https://specstream.ai/data/form-d/company/crosslink-therapeutics-inc-2067583) $5.5 million · Oct 20, 2026
- [Sentonix, Inc.](https://specstream.ai/data/form-d/company/sentonix-inc-2039609) $12.7 million · Aug 20, 2026

[Every Form D from the week of Nov 12, 2018](https://specstream.ai/data/form-d/week/2018-11-12) · [All recent filings in Massachusetts](https://specstream.ai/data/form-d/state/massachusetts) · [All recent Pharmaceuticals filings](https://specstream.ai/data/form-d/industry/pharmaceuticals)

Read from SEC EDGAR. Amount sold is what COLLEGIUM PHARMACEUTICAL, INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).